The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
spirogen | 374 |
medimmune | 254 |
adc therapeutics | 123 |
seattle genetics | 89 |
masterson, luke | 59 |
genentech | 59 |
spirogen developments | 25 |
stem centrx | 16 |
starks associates | 6 |
abbvie stemcentrx | 4 |
spirogen | 19 |
starks associates | 2 |
masterson, luke | 2 |
medimmune | 74 |
adc therapeutics | 44 |
seattle genetics | 9 |
spirogen | 5 |
abbvie stemcentrx | 3 |
genentech | 3 |
masterson, luke | 2 |
spirogen developments | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
pyrrolobenzodiazepine-antibody conjugates | 168 | 2012 |
pyrrolobenzodiazepines and conjugates thereof | 41 | 2010 |
unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases | 35 | 2008 |
pyrrolobenzodiazepines and conjugates thereof | 33 | 2011 |
pyrrolobenzodiazepines and targeted conjugates | 29 | 2011 |
targeted pyrrolobenzodiazapine conjugates | 29 | 2010 |
pyrrolobenzodiazepines used to treat proliferative diseases | 24 | 2010 |
novel antibody conjugates and uses thereof | 24 | 2013 |
pyrrolobenzodiazepine-antibody conjugates | 24 | 2013 |
anti-cd22 antibodies and immunoconjugates | 23 | 2012 |